The purpose of this Western blot experiment was not to compare the quantities of uPAR (I−III) and uPAR (II−III) in the individual sample but to show that they are present and that the levels are higher in the tumour tissue than in the adjacent benign-appearing tissue. The gene discussed is PLAUR; the disease is neoplasm.